Article

Identification and preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral and anti-inflammatory therapy

2022-04-07

Abstract excerpt

<title>Abstract</title> <p>Orally available antivirals against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still scarce and the emergence of new variants challenging immunized individuals, suggests that mutant viruses might also emerge because of antiviral pressure. Therefore, beyond the recently alleged positive antiviral clinical results with molnupiravir™ and paxlovid™, the continuous sear...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: df9bf173-e73b-5726-90ba-fbeade56d9eb
DOI: 10.21203/rs.3.rs-1533971/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification and preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral and anti-inflammatory therapyDOI 10.21203/rs.3.rs-1533971/v1Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

Anthracyclines inhibit SARS-CoV-2 infectionSemantic proximity Read

COVID-19 Infection: Targeting Possibilities for Treatment.Semantic proximity Read

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in miceSemantic proximity Read

Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive EvaluationSemantic proximity Read

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?Semantic proximity Read

A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseasesSemantic proximity Read

Reducing SARS-CoV-2 pathological protein activity with small moleculesSemantic proximity Read

Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2Semantic proximity Read

CIGB-300 Synthetic Peptide, an Antagonist of CK2 Kinase Activity, as a Treatment for Covid-19. A Computational Biology ApproachSemantic proximity Read

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoSemantic proximity Read

Pyronaridine Protects Against SARS-CoV-2 in MouseSemantic proximity Read